Osteoarthritis Clinical Trials

Find Osteoarthritis Clinical Trials Near You

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip- and/or Knee Osteoarthritis

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA). Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks. The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA. To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Healthy Volunteers: f
View:

• Currently listed on the waiting list for an osteoarthritis rehabilitation program due to clinically diagnosed hip and/or knee osteoarthritis.

Locations
Other Locations
Sweden
Närhälsan Gibraltar Rehab
RECRUITING
Gothenburg
Contact Information
Primary
Daniel Karsberg Zotterman, MSc
daniel.karsberg.zotterman@vgregion.se
+46739298119
Backup
Stefan Lundqvist, PhD
stefan.lundqvist@vgregion.se
+46762276179
Time Frame
Start Date: 2026-04-21
Estimated Completion Date: 2027-10-01
Participants
Target number of participants: 40
Treatments
Experimental: Forty patients with osteoarthritis in hip or knee
Forty patients with hip or knee osteoarthritis on the waiting list for usual rehabilitation care will be recruited. The patientes will be screened for contraindications, and, if eligible, will complete a submaximal cycle ergometer test twice within one week.
Related Therapeutic Areas
Sponsors
Leads: Vastra Gotaland Region

This content was sourced from clinicaltrials.gov